MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells

MY Hanafi-Bojd, SA Moosavian Kalat… - Drug development …, 2018 - Taylor & Francis
In the present study, we developed aptamer (Apt) conjugated mesoporous silica
nanoparticles (MSNs) for specific delivery of epirubicin (EPI) to breast cancer cells. MSNs …

MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.

MY Hanafi-Bojd, MK SA, SM Taghdisi… - Drug Development …, 2017 - europepmc.org
In the present study, we developed aptamer (Apt) conjugated mesoporous silica
nanoparticles (MSNs) for specific delivery of epirubicin (EPI) to breast cancer cells. MSNs …

MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells

MY Hanafi-Bojd, SAM Kalat… - Drug development …, 2018 - pubmed.ncbi.nlm.nih.gov
In the present study, we developed aptamer (Apt) conjugated mesoporous silica
nanoparticles (MSNs) for specific delivery of epirubicin (EPI) to breast cancer cells. MSNs …